The short answer
Trans men and nonbinary people with ovaries go through the natural decline in ovarian hormones in midlife. On testosterone, many symptoms such as hot flashes are reduced, but changes can still appear, especially if testosterone is stopped or interrupted. After removal of the ovaries, a steady sex hormone replacement is needed to protect bone. Vaginal and pelvic tissue may become dry or tender on testosterone. A licensed clinician experienced in gender-affirming care can plan treatment that respects your gender.
No advertising or analytics trackers run on Specialized Care pages. Reading them is never linked to your identity. Our privacy pledge
How midlife hormone changes can show up
Ovarian hormone production declines in midlife for everyone with ovaries. On a stable testosterone dose, many people notice few vasomotor symptoms. Hot flashes, sleep disruption or mood changes can appear when testosterone levels are low, missed or stopped.
Your clinician should use your name and pronouns, ask about your body and history without assumptions, and never make care conditional on explaining your identity. You share what is relevant to you.
After removal of the ovaries
Removing the ovaries ends their hormone production immediately. Endocrine Society and WPATH guidance stress continuing sex hormone therapy afterwards, because long periods without adequate hormones raise the risk of bone loss. If you need to pause testosterone, talk with your clinician about how to protect bone in the meantime.
Pelvic and genital health
Testosterone can thin vaginal and urethral tissue, which can cause dryness, pain with penetration, spotting or urinary symptoms. Low-dose vaginal estrogen acts locally with minimal absorption and does not typically counter the effects of testosterone elsewhere in the body. Non-hormonal moisturizers are another option.
Screening and long-term health
- Cervical screening if you have a cervix; self-collected HPV testing may be more comfortable where offered
- Breast or chest screening if breast tissue remains, based on your history
- Bone density screening, earlier if hormones have been interrupted
- Blood pressure, red blood cell count, cholesterol and glucose checks on testosterone
Specialized care pathway
Care that respects your values
A licensed Kindr clinician can review your symptoms and health history, listen to your preferences, and discuss options, including hormone therapy or non-hormonal treatment, when medically appropriate.
Questions, answered
Common questions
Do trans men go through menopause?
+
If you have ovaries, their hormone production declines in midlife. Testosterone can mask many symptoms, but bone, pelvic and mood changes can still occur.
Can I get hot flashes on testosterone?
+
It is possible, particularly if levels drop between doses or after stopping. Tell your clinician; dose timing often helps.
Will vaginal estrogen make me feminine?
+
Low-dose vaginal estrogen works locally with very little reaching the bloodstream. It is used to treat dryness and pain without counteracting testosterone.
What happens to my bones after oophorectomy?
+
Without ovaries, bone depends on the hormone therapy you take. Continuing testosterone or another sex hormone is important to prevent bone loss.
Do I need a gynecologic exam?
+
Most menopause telehealth visits do not need a physical exam. If screening needs an exam, you can ask about options that feel more comfortable.
WRITTEN & MEDICALLY REVIEWED BY
Kindr Health Clinical Team
Kindr Health Inc. — Editorial & Clinical Team, led by Kevin Wolfe, CMO
Kindr’s clinical content is written and reviewed by board-certified clinicians who prescribe hormone therapy every day across all 50 states — menopause-focused physicians, nurse practitioners, and pharmacists working under Kindr Health, Inc.’s organizational clinical oversight. Every page is checked against current NAMS and ACOG guidance, FDA labeling, and the primary literature before publication, then re-reviewed on a rolling schedule when guidance changes.
Organizational NPI 1609792902 · Last reviewed October 5, 2026 · Editorial policy
Educational content only — not a substitute for individual medical advice, diagnosis, or treatment.
SOURCES & REFERENCES
Every clinical claim on this page is sourced.
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society Clinical Practice Guideline (Hembree WC, et al.) (2017) — Journal of Clinical Endocrinology & Metabolism. doi.org/10.1210/jc.2017-01658
- Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 (2022) — World Professional Association for Transgender Health (WPATH). doi.org/10.1080/26895269.2022.2100644
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society (2022) — The Menopause Society. www.menopause.org/docs/default-source/professional/nams-2022-hormone-therapy-position-statement.pdf
- The 2020 Genitourinary Syndrome of Menopause Position Statement (2020) — The Menopause Society. pubmed.ncbi.nlm.nih.gov/?term=2020+genitourinary+syndrome+of+menopause+position+statement
- Cervical Cancer: Screening recommendation (2018) — U.S. Preventive Services Task Force. www.uspreventiveservicestaskforce.org/uspstf/recommendation/cervical-cancer-screening
- Menopause in LGBTQ+ people: a scoping review (Kalbarczyk & Morgan) (2026) — The Lancet Obstetrics, Gynaecology, & Women’s Health. pubmed.ncbi.nlm.nih.gov/?term=Kalbarczyk+Morgan+menopause+LGBTQ